osimertinib
astrazeneca
['nsclc', 'sclc', ' 995p', 'osimertinib']
today #esmo2022, dr camille mehlman presents the preliminary results of composit study which evaluates the combination of osimertinib with another targeted therapy in egfrm nsclc. come to see us - poster 995p
great multicentric cooperation 
Pneumologue Oncologue Thoracique - @Hopitaltenon @MedecineSU #IUC  @IFCTlung @reseauKpoumon